Design of potent dynorphin A-(1-9) analogues devoid of supraspinal motor effects in mice

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 1, 1997, Pages 9-14

  Le, Hoang Thanh ^a   Michelot, Robert ^a   Dumont, Michel ^b   Shukla, Vijay Kumar ^b   Mayer, Michel ^a   Nguyen, Kim Phi Phung ^a   Ruan, Hong ^b   Lemaire, Simon ^b  

^a CNRS   (France)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Analgesia; Dynorphin; Endothiopeptides; Motor impairment; Opioid receptor

Indexed keywords

DYNORPHIN DERIVATIVE; DYNORPHIN[1-9]; OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CEREBELLUM; CONTROLLED STUDY; DRUG DESIGN; DRUG RECEPTOR BINDING; GUINEA PIG; ILEUM; IN VITRO STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION;

EID: 0030895012     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-152     Document Type: Article

References (32)

1. Benuck, M., Berg, M.J., and Marks, N. 1984. Membrane-bound enzymes and their role in processing of the dynorphins and the proenkephalin octapeptide Met-enkephalin-Arg-Gly-Leu. Neurochem. Res. 9: 733-749.
2. Chavkin, C., James, I.F., and Goldstein, I. 1982. Dynorphin is a specific endogenous ligand of the kappa opioid receptors. Science (Washington, D.C.), 215: 413-415.
3. 50) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108.
4. 3H]CGP-39653 binding to rat brain membranes. Eur. J. Pharmacol. 271: 241-244.
5. Faden, A.I. 1990. Opioid and non-opioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury. Ann. Neurol. 27: 67-74.
6. Gacel, G., Fournie-Zaluski, M.C., and Roques, B.P. 1980. Tyr-D-Ser-Gly-Phe-Leu-Thr, a highly preferential ligand for 8-opiate receptors. FEBS Lett. 118: 245-247.
7. Goldstein, A., Tachibana, S., Lowney, L.I., Hunkapiller, M., and Hood, L. 1979. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. U.S.A. 76: 6666-6670.
8. Handa, B.K., Lane, A.C., Lord, J.A.H., Morgan, B.A., Rance, M.J., and Smith, C.F.C. 1981. Analogues of β-LPH 61-64 possessing selective agonist activity at the μ opiate receptors. Eur. J. Pharmacol. 70: 531-540.
9. Herman, B.H., and Goldstein, A. 1985. Antinociception and paralysis induced by intrathecal dynorphin A. J. Pharmacol. Exp. Ther. 232: 27-32.
10. Hirao, T., and Takahashi, K. 1984. Purification and characterization of a calcium-activated neutral protease from monkey brain and its action on neuropeptides. J. Biochem. 96: 775-784.
11. Huidoro-Toro, J.P., Yoshimura, K., Lee, N.M., and Way, E.L. 1981. Dynorphin interaction at the kappa-opiate site. Eur. J. Pharmacol. 72: 265-266.
12. Kosterlitz, H.W., and Waterfield, A.A. 1975. In vitro models in the study of structure-activity relationships of narcotic analgesics. Annu. Rev. Pharmacol. 15: 29-47.
13. Leighton, G.E., Johnson, M.A., Muchana, K.G., Hill, R.G., and Hughes, J. 1987. Pharmacological profile of PD117302, a selective κ-opioid agonist. Br. J. Pharmacol. 92: 915-922.
14. Lemaire, S., Lafrance, L., and Dumont, M. 1986. Synthesis and biological activity of dynorphin-(1-13) and analogues substituted in position 8 and 10. Int. J. Pept. Protein Res. 27: 300-305.
15. Leslie, F.M. 1987. Methods used for the study of opioid receptors. Pharmacol. Rev. 39: 197-249.
16. Litchfield, J.T., and Wilcoxon, F. 1949. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96: 99-113.
17. Lowry, O.H., Rosenbrough, M.J., Farr, A.L., and Randall, A.J. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-270.
18. 19: a potent and selective κ opioid peptide. Eur. J. Pharmacol. 196: 161-167.
19. Merrifield, R.B. 1963. Solid-phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85: 2149-2154.
20. Meyer, J.P., Gillespie, T.J., Horn, S., Hruby, V.J., and Davis, T.P. 1995. In vitro stability of some reduced peptides bond pseudopeptide analogues of dynorphin A. Peptides, 10: 1215-1219.
21. Michelot, R.J., Le, H.T., and Mayer, M. 1996. Solid-phase synthesis of endothiopeptides using 3-(N-Boc-amino thioacyl)-1,3-thiazolidine-2-thiones: new efficient thioacylating reagents. In Innovation and perspectives in solid-phase synthesis, biological and biomedical applications. Edited by R. Epton. Mayflower Worldwide Inc., Birmingham. In press.
22. Nakazawa, T., Furuya, Y., Kaneko, T., Yamatsu, K., Yoshino, H., and Tachibana, S. 1990. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice. J. Pharmacol. Exp. Ther. 252: 1247-1254.
23. Nyberg, F., Lyrenas, S., and Terenius, L. 1986. Assay and biochemical characterization of a dynorphin enzyme in human cerebrospinal fluid. NIDA Res. Monogr. 75: 251-254.
24. Robson, L.E., Foote, R.W., Mauer, R., and Kosterlitz, K.W. 1984. Opioid binding sites of the κ-type in guinea-pig cerebellum. Neuroscience (Oxford), 12: 621-627.
25. Shukla, V.K., and Lemaire, S. 1994. Non-opioid effects of dynorphins: possible role of the NMDA receptor. TIPS (Trends Pharmacol. Sci.), 15: 420-424.
26. Shukla, V.K., Bansinath, M., Dumont, M., and Lemaire, S. 1992. Selective involvement of kappa opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1-13)-Tyr-Leu- Phe-Asn-Gly-Pro. Brain Res. 591: 176-180.
27. Shukla, V.K., Lemaire, S., Ibrahim, I.H., Cyr, T.D., Chen, Y., and Michelot, R. 1993. Design of potent and selective dynorphin A related peptides devoid of supraspinal motor effects in mice. Can. J. Physiol. Pharmacol. 71: 211-216.
28. 3H]CGP-39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain. Eur. J. Pharmacol. 192: 19-26.
29. Tachibana, S., Yoshino, H., Arakawa, Y., Nakazawa, T., Kaneko, T., Yamatsu, K., and Miyagawa, H. 1988. Design and synthesis of metabolically stable analogues of dynorphin-A and their analgesic characteristics. In Biowaming system in the brain. Edited by H. Takagi, Y. Oomoro, M. Ito, and H. Otsuka. University of Tokyo Press, Tokyo.
30. Tallarida, R.J., and Murray, R.B. 1987. Manual of pharmacological calculations with computer programs. 2nd ed., Springer, New York.
31. Yoshino, H., Nakazawa, T., Arakawa, Y., Kaneko, T., Tsuchiya, Y., Matsunaga, M., Araki, S., Ikeda, M., Yamatsu, K., and Tachibana, S. 1990. Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues. J. Med. Chem. 33: 206-212.
32. Zacharie, B., Martel, R., Sauvé, G., and Belleau, B. 1993. Chemo-selective thioacylation of amino acids. Preparation of the four monothiothymopentin analogs and their biological activity. Bioorg. Med. Chem. Lett. 3: 619-624.